Erlotinib vs Ranitidine

Erlotinib vs Ranitidine: Overview

This comparison examines the pharmacological differences between Erlotinib and Ranitidine.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Ranitidine: Competitive H2 receptor antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Ranitidine — 2-3 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Ranitidine — C13H22N4O3S.

Molecular Weight: Erlotinib — 393.4380 g/mol; Ranitidine — 314.4050 g/mol.

Type: Erlotinib — Small molecule; Ranitidine — Small molecule.